BioSpace News Archive

Genetown

X4 Pharma Release: First Clinical Data From Combination of X4P-001-IO and Keytruda (pembrolizumab) in Patients With Melanoma Will Be Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

X4P-001, an Orally Bioavailable CXCR4 Antagonist, Increases T-cell Infiltration in Human Metastatic Melanoma

November 3, 2017
·
3 min read
Biotech Bay

Bigfoot Biomedical Presents Data From Clinical Research Center Trial and Simulation Modeling at Diabetes Technology Meeting

The trial provided validation for Bigfoot’s groundbreaking in-silico metabolic simulation engine.

November 3, 2017
·
3 min read
Business

Merck and CDRD Announce Joint Investment in the Canadian Life Sciences Ecosystem

The Centre for Drug Research and Development, announced the establishment of a new $1.5M Merck-CDRD Innovation Fund.

November 3, 2017
·
4 min read
Lone Star Bio

Bio-Path Holdings Announces $4M Registered Direct Offering

The offering price per share of common stock and one-half warrant is $0.30.

November 3, 2017
·
3 min read
Drug Development

Presentations at ASN Kidney Week 2017 Highlight ChemoCentryx Platform in Treatment of Kidney Diseases ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS)

The world’s premier nephrology meeting is being held October 31 to November 5 in New Orleans, LA.

November 3, 2017
·
7 min read
Policy

Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of the IND Application for the GALGT2 Gene Therapy Program

Nationwide Children’s Hospital is on track to initiate a Phase 1/2a clinical trial in individuals with Duchenne muscular dystrophy by year-end 2017.

November 3, 2017
·
7 min read
Business

Sientra to Release Third Quarter 2017 Financial Results

Sientra will hold a conference call on Tuesday, November 7, 2017 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results.

November 3, 2017
·
3 min read
Business

AIT Therapeutics Reports Third Quarter 2017 Financial Results

The Company had cash and cash equivalents of $3.8 million at September 30, 2017, compared to $5.2 million at June 30, 2017.

November 3, 2017
·
15 min read
Genmab’s Financial Calendar for 2018

Shareholders must submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors no later than Monday, February 26, 2018.

November 3, 2017
·
3 min read
Business

Obalon Announces Third Quarter 2017 Financial Results

Revenue grew 42% sequentially over Q2-17 to $2.8 million.

November 3, 2017
·
6 min read